The spinal endocannabinoid system has a dual role in neuropathic pain: it typically provides pain relief, but under certain pathological conditions it can paradoxically promote pain transmission.
Researchers and clinicians interested in cannabinoid-based pain management and the neuroscience of neuropathic pain.
Dual role: pain relief or pain facilitation depending on conditions
What the researchers found
This review reveals that the spinal endocannabinoid system's role in pain is context-dependent. While numerous studies show antinociceptive and neuroprotective effects, emerging evidence indicates that under specific pathological conditions, endocannabinoid system activation in the spinal cord can facilitate rather than inhibit pain transmission. The balance depends on cellular, molecular, and pathophysiological factors.
Why it matters
Neuropathic pain is largely treatment-resistant, affecting millions. Understanding when the endocannabinoid system helps vs hurts pain could explain why some patients with nerve pain report cannabis helps while others find it ineffective or worsening.
The numbers in context
The review covers CB1 and CB2 receptor roles, endocannabinoid enzyme systems, and multiple neuropathic pain models demonstrating bidirectional effects.
How the study worked
Narrative review integrating evidence on the spinal endocannabinoid system's bidirectional effects in neuropathic pain, examining cellular, molecular, and pathophysiological mechanisms.
What this study cannot tell us
Narrative review synthesizing primarily preclinical evidence. The conditions determining pro- vs anti-nociceptive effects are not yet fully characterized. Clinical translation of spinal cord-specific findings is challenging.
How to read the evidence
Moderate: comprehensive mechanistic review, but primarily preclinical evidence with limited clinical translation.
When this study was published
Published in 2025.
The bigger picture
The dual nature of spinal endocannabinoid signaling means that blanket cannabinoid therapy for nerve pain may not work for everyone. Understanding the conditions that flip the switch from pain relief to pain facilitation is crucial for developing targeted treatments.
Questions still open
- What determines whether the spinal endocannabinoid system relieves or worsens pain?
- Could diagnostic tests predict which patients would benefit from cannabinoid pain therapy?
- Can spinal cord-targeted cannabinoid delivery avoid the dual-effect problem?
Common questions
Does the endocannabinoid system help with nerve pain?
Why doesn't cannabis always help with chronic pain?
Read the original research
Dual Role of the Spinal Endocannabinoid System in Response to Noxious Stimuli: Antinociceptive Pathways and Neuropathic Pain Mechanisms.
International journal of molecular sciences, 26(21)
Citation
Saldaña, Raquel; Carrascosa, Antonio J; Torregrosa, Abraham B; Navarrete, Francisco; García-Gutiérrez, María Salud; Manzanares, Jorge. (2025). Dual Role of the Spinal Endocannabinoid System in Response to Noxious Stimuli: Antinociceptive Pathways and Neuropathic Pain Mechanisms.. International journal of molecular sciences, 26(21). https://doi.org/10.3390/ijms262110692
Explore the wider topic
- CBD Oil Quality Guide: How to Avoid Snake Oil
- Anxiety After Quitting Weed: When to Consider Medication
- Cannabis for Chemotherapy Nausea: What the Evidence Actually Shows
- Cannabis for Chronic Pain: What the Research Actually Supports
- Cannabis and Epilepsy: The Epidiolex Story and What It Means
- Does CBD Actually Work for Anxiety? What the Evidence Shows
- Does CBD Help with Weed Withdrawal? What Studies Show
- CBD vs THC: The Differences That Actually Matter
- The Proven Medical Benefits of Cannabis: What Research Supports
- Quitting Weed Before Surgery
- Weed and Medications: What Changes When You Quit
- Quitting Weed During Pregnancy: What You Need to Know
- Quitting Weed While Pregnant: What You Need to Know
- Cannabis and Older Adults: Risks Seniors Should Know
- Cannabis and Breastfeeding: THC in Breast Milk